Cellumed
Cellumed is a leading biotech company based in South Korea, dedicated to contributing to human health and happiness through innovative research and development of various bio products. The company specializes in musculoskeletal medical devices, growth factors, RNA enzymes, and healthcare devices, aiming to grow as a global leader in biotechnology with high-quality products that enhance the quality of life.
Industries
Nr. of Employees
medium (51-250)
Cellumed
130 Digital-ro, Geumcheon-gu, Seoul, South Korea, 402, Namseong Plaza
Patents
Products
Orthopedic demineralized bone matrix grafts
Demineralized bone matrix (DBM) products intended for filling bone defects and supporting bone regeneration in orthopedic indications.
Dental bone graft materials
Bone graft products formulated for dental and oral surgery applications, produced under tissue-based manufacturing processes.
Recombinant growth factor products
Growth factor proteins developed via cell line development and scaled production for applications in skin, bone, cartilage, and wound healing.
Enzyme proteins for mRNA production
Enzyme proteins used in early-stage synthesis workflows for mRNA vaccines and therapeutics, developed for use in manufacturing processes.
Medical devices using metals and ceramics
Manufacture of implantable medical devices and components using medical-grade metals and ceramics for various clinical indications.
Orthopedic demineralized bone matrix grafts
Demineralized bone matrix (DBM) products intended for filling bone defects and supporting bone regeneration in orthopedic indications.
Dental bone graft materials
Bone graft products formulated for dental and oral surgery applications, produced under tissue-based manufacturing processes.
Recombinant growth factor products
Growth factor proteins developed via cell line development and scaled production for applications in skin, bone, cartilage, and wound healing.
Enzyme proteins for mRNA production
Enzyme proteins used in early-stage synthesis workflows for mRNA vaccines and therapeutics, developed for use in manufacturing processes.
Medical devices using metals and ceramics
Manufacture of implantable medical devices and components using medical-grade metals and ceramics for various clinical indications.
Services
Processing, storage, and distribution of human tissues for surgical grafting and tissue-engineered products.
Joint development projects with external contract development/manufacturing organizations for enzyme and biologics production.
Research and development of healthcare devices that integrate IT features to meet specific clinical or user needs.
Processing, storage, and distribution of human tissues for surgical grafting and tissue-engineered products.
Joint development projects with external contract development/manufacturing organizations for enzyme and biologics production.
Research and development of healthcare devices that integrate IT features to meet specific clinical or user needs.
Expertise Areas
- Tissue banking and tissue engineering
- Bone graft and dental graft manufacturing
- Biomaterials development (natural and synthetic)
- Growth factor and protein biologics development
Key Technologies
- Tissue banking processes
- Demineralized bone matrix production
- Medical-grade metals and ceramic processing
- Cell line development
News & Updates
Cellumed is utilizing AI technology AlphaFold 3 to develop next-generation bone grafts with enhanced osteogenesis and biocompatibility.
Cellumed has achieved its highest monthly production of bone grafts, strengthening its competitiveness in domestic and international markets.
Cellumed's production of bone grafts reached a record high, demonstrating its manufacturing capabilities and market competitiveness.
Cellumed is utilizing AI technology AlphaFold 3 to develop next-generation bone grafts with enhanced osteogenesis and biocompatibility.
Cellumed has achieved its highest monthly production of bone grafts, strengthening its competitiveness in domestic and international markets.
Cellumed's production of bone grafts reached a record high, demonstrating its manufacturing capabilities and market competitiveness.